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Abstract 
Deoxyribonucleic acid inside cells is being damaged continually. Cells have evolved a 
series of complex mechanisms to repair all types of damage. Deficiencies in these repair 
pathways can result in several different genetic disorders. In many cases these are 
associated with a greatly elevated incidence of specific cancers. Other disorders do not 
show increased cancer susceptibility, but instead they present with neurological 
abnormalities or immune defects. Features of premature ageing also often result. These 
disorders indicate that DNA repair and damage response processes protect us from 
cancer and are important for the maintenance of a healthy condition. 
Keywords: UV light; xeroderma pigmentosum; ataxia telangiectasia; cancer; 
immunodeficiency; DNA repair. 
 
Key concepts 
 DNA is damaged continually from both endogenous and exogenous sources. 
 Cells have evolved many different ways for repairing different types of damage 
 Genetic defects in these pathways result in different disorders 
 Defective DNA repair often results in an increased mutation frequency and 
consequent elevated incidence of cancer. Many of the DNA repair disorders are 
highly cancer-prone. 
 The central nervous system appears to be particularly sensitive to DNA breaks. 
Several disorders caused by defective break repair are associated with 
neurological abnormalities including mental retardation, ataxia and microcephaly. 
 Development of immunological diversity uses some of the enzymes required to 
repair double-strand breaks. Disorders caused by defects in this process are 
associated with immune deficiencies. 
 
1. Introduction  
Deoxyribonucleic acid (DNA) inside all cells is continually being damaged, both from 
endogenous reactions, such as hydrolysis and oxidation, and by exogenous agents, like 
ultraviolet light and chemical carcinogens. In order to survive this potentially devastating 
loss of genetic information, cells have evolved a variety of repair and response pathways 
for either removing the damage or coping with unrepaired damage. If any of these 
processes is faulty, the result is either a genetic disorder or death if the defect is not 
compatible with life. More than twenty distinct disorders, representing about 50 genes, 
are known to be associated with such defects, and more are being revealed each year. 
2. Ultraviolet Sensitivity: Disorders of Nucleotide Excision Repair  
Ultraviolet light (UV) and many chemical carcinogens produce alterations in the DNA that 
result in bulky distortions. This damage is removed by a complex pathway designated 
nucleotide excision repair (NER), a process involving many proteins (Figure 1) 
(Nouspikel, 2009). A defect in any one of seven of these proteins (XPA to XPG) results in 
the disorder xeroderma pigmentosum (XP) (Figure 2a). XP is characterized by sensitivity 
of the skin to sunlight, various pigmentation changes and multiple skin cancers on sun-
exposed areas. In a minority of cases there are associated neurological abnormalities 
(Kraemer et al., 1987). The XP proteins are involved in recognition of DNA damage 
(XPC, XPE), opening out of the damaged structure (XPB, XPD helicases), verification of 
the damage (XPA) and cutting the DNA strand on either side of the damage (XPG, XPF 
nucleases) (Nouspikel, 2009). See also DNA Repair, and Skin: Hereditary Disorders 
[figure 1 here] 
[figure 2 here] 
XPB and XPD are two of the subunits of TFIIH, a protein complex with two distinct 
functions. Before its role in NER was discovered, it had been found to be a basal 
transcription factor required for initiation of all transcription mediated by RNA 
polymerase II. In both repair and transcription functions, it carries out a similar but not 
identical role of opening out the DNA structure. Both XPB and XPD are helicases (of 
opposite polarity). The helicase activity of XPB is required for transcription initiation, but 
not NER, whereas the XPD helicase activity is required for NER but not for initiation of 
transcription (Hashimoto and Egly, 2009). See also DNA Helicases 
Mutations in XPB and especially XPD can result not only in XP, but also in 
trichothiodystrophy (TTD) or rarely in the combined features of XP and Cockayne 
syndrome (CS). TTD (Figure 2b) is a multisystem disorder characterized by sulfur-
deficient brittle hair, ichthyotic skin, beta thalassemia trait, physical and mental 
retardation and sun sensitivity, but, in contrast to XP, no pigmentation changes or 
increase in skin cancers (Hashimoto and Egly, 2009; Stefanini et al., 2010). Different 
mutations in the gene encoding the XPD protein cause the different clinical disorders, 
and it is widely accepted that the features of XP result from defective repair, while TTD 
features are caused by subtle abnormalities in transcription (Lehmann, 2001). 
The initial damage-recognition step of NER differs if the damage is on the transcribed 
strand of an active gene. In this case the XPC protein is dispensable, and the recognition 
signal in this „transcription-coupled repair‟ is thought to derive from ribonucleic acid 
(RNA) polymerase molecules stalled at damaged sites (Figure 1) (Fousteri and 
Mullenders, 2008). The two proteins defective in patients with CS, namely CSA and CSB, 
are required to displace the stalled RNA polymerase and recruit the proteins involved in 
the later steps of NER (Fousteri et al., 2006). The clinical features of CS (Figure 2c) 
include dwarfism with severe physical and mental retardation, progressive neurological 
and retinal degeneration, ataxic gait, deafness and sun sensitivity, but again no 
pigmentation changes or skin cancer (Nance and Berry, 1992). The CS proteins are 
required for transcription-coupled repair, not only of UV damage but also for repair of 
some types of oxidative damage. It is thought that the clinical features of the disorder 
may result from the accumulation of oxidative damage. The CS proteins are also thought 
to have a nonessential role in transcription. Combined features of XP and CS are found in 
rare individuals with mutations in the genes encoding the XPB, XPD and XPG proteins. 
See also Transcription-coupled DNA Repair 
  
3. Disorders of Replication of Deoxyribonucleic acid damaged by ultraviolet 
light  
Although DNA damage is normally removed by NER, it is a relatively slow and incomplete 
process, and cells need to replicate past unrepaired DNA damage (translesion synthesis 
(TLS)). Replicative DNA polymerases are unable to carry out TLS, and so the cell 
employs low-fidelity distributive polymerases, which are able to carry out TLS past 
different types of damage. About 20% of XP patients have normal NER but are defective 
in DNA polymerase , a specialised DNA polymerase that is able to carry out TLS past UV 
photoproducts and other types of DNA adducts (Masutani et al., 2000; McCulloch et al., 
2004). Both NER-defective and TLS-defective XP cells are highly mutable by UV light, 
and it is this hypermutability that gives rise to the skin cancers that are associated with 
the disease. See also DNA Polymerases: Eukaryotic, DNA Mismatch Repair: Eukaryotic and DNA 
Replication Fidelity 
 
4. Abnormal Responses to Damage by Ionizing Radiation  
Unlike UV, the most important damage generated in DNA by ionising radiation are 
double strand breaks (DSB‟s). At least two mechanisms are available to repair these 
breaks, nonhomologous end joining (NHEJ) and homologous recombination (HR). NHEJ 
is essentially a DSB re-sealing pathway but often involves loss of genetic material at the 
DSB termini so is regarded as an „error-prone‟ type of repair. HR, on the other hand, 
copies the identical sister DNA molecule and consequently is an „error free‟ type of 
repair. Sister chromatids are, however, only available at certain stages of the cell cycle 
after DNA replication (S/G2), so that HR is limited to these periods of the cell cycle. 
Several genetic disorders are associated with abnormal responses to ionizing radiation.  
4.1 Disorders of Nonhomologous end joining (NHEJ)  
The major pathway for repairing DSB in human cells is NHEJ (Figure 3). In this process, 
the Ku 70-80 heterodimer binds to the ends of the DSB and recruits the catalytic subunit 
of DNA-dependent protein kinase (DNA-PKCS), resulting in activation of its kinase 
activity. The breaks are subsequently joined by DNA ligase IV which exists in a tight 
complex with XRCC4 and XLF (XRCC4-like factor)/Cernnunos (Lieber, 2010). The same 
set of proteins are required to rejoin programmed breaks generated in the V(D)J 
recombination process during development of immunoglobulins and T cell receptors. 
Thus there is a strong link between repair of ionising radiation damage and development 
of the immune response. The severe combined immunodeficient (SCID) mouse is 
mutated in DNA-PKCS and is radiation sensitive and immunodeficient and a single 
immunocompromised individual with point mutations in DNA-PK has been described (van 
der Burg et al., 2009). As yet no human disorder has been associated with defects in Ku. 
However several immunodeficient individuals with deficient DSB-repair have been 
identified as having mutations in the gene for DNA ligase IV and for XLF/Cernnunos 
(O'Driscoll et al., 2001). Both sets of patients exhibit overlapping clinical features of 
pancytopenia, microcephaly, and developmental delay. Other immunodeficient and 
radiation-sensitive individuals were found to be defective in a protein designated Artemis 
(Moshous et al., 2001). This protein is found in a complex with DNA-PKCS, and is a 
substrate for its kinase activity. When phosphorylated by DNA-PKCS, Artemis is able to 
open hairpin structures generated as intermediates in V(D)J recombination thereby 
explaining their SCID phenotype (Ma et al., 2002). Nevertheless, whilst the exact role of 
Artemis in DSB-repair is unclear, Artemis-defective cells exhibit ionising radiation 
sensitivity and and DSB repair defect epistatic to that of A-T cells.   
[figure 3 here] 
4.2 Disorders of Homologous recombination (HR) 
The alternative mechanism for repairing DSB involves homologous recombination to 
restore the genetic information lost at the site of the break. This process requires several 
human homologues of the Saccharomyces cerevisiae Rad51 protein, as well as 
homologues of the Rad52 and Rad54 proteins.  Recently, mutations in RAD51C a gene 
encoding a RAD51 paralogue have been associated with breast and ovarian cancer 
pedigrees as well as in a single family exhibiting a developmental disorder (with multiple 
congenital abnormalities and with cellular features reminiscent of Fanconi anaemia-
derived cell lines) (Meindl et al., 2010; Vaz et al., 2010).  
The majority of familial breast cancers result from mutations in the breast cancer 1 
(BRCA1, early onset) or breast cancer 2, early onset (BRCA2) genes. These individuals 
are heterozygous for the defective gene, and the tumours result when the second allele 
is also lost or mutated. Cell lines derived from these tumours have been tested for their 
ability to carry out homologous recombination and were found to be defective. 
Furthermore both BRCA1 and BRCA2 proteins interact with RAD51 (Gudmundsdottir and 
Ashworth, 2006). Both genes are essential, but cells with hypomorphic mutations are 
sensitive to ionizing radiation and exhibit chromosome instability. Taken together, these 
findings implicate BRCA1 and BRCA2 in homologous recombination, although they 
undoubtedly have other functions as well. BRCA1 mutants are also defective in some of 
the ionizing radiation-induced cell-cycle checkpoints (see below). See also DNA 
Recombination 
5. Detecting and responding to DNA strand discontinuities 
 
The signal transduction cascade enacted upon DNA breakage (Figure 4) is controlled by 
two functionally overlapping protein kinases, ATM (ataxia telangiectasia mutated) and 
ATR (ataxia telangiectasia and Rad3-related). This cascade coordinates the activation of 
downstream events including cell cycle checkpoint arrest mechanisms, DNA repair 
pathways and even when appropriate, apoptosis. ATM is activated rapidly upon DSB 
formation, whilst ATR is activated by single stranded regions of DNA (ssDNA), which can 
occur, for example, following DNA replication fork stalling or after resection of DSB ends 
to facilitate recombination/repair. One of the earliest detectable events at a DNA strand 
break is the phosphorylation of the histone H2A variant H2AX. This helps to recruit 
various 'mediator' proteins such as 53BP1 and MDC1 which are important facilitators of 
these downstream events. Emerging evidence indicates that other post-translational 
modifications aside from phosphorylation such as ubiquitylation and sumoylation are 
vitally important for cellular responses to DSBs (Zlatanou and Stewart). 
 
[figure 4 here] 
 
5.1 Ataxia-telangiectasia, Ataxia telangiectasia-like Disorder and Nijmegen 
breakage syndrome  
Patients with ataxia-telangiectasia (A-T) have progressive cerebellar ataxia, 
telangiectases in the eyes and face and various immune deficiencies. Their blood cells 
have a variety of chromosome aberrations, particularly translocations between 
chromosomes 7 and 14, which is where the immunoglobin and T cell receptor coding 
genes reside. Affected individuals are also very susceptible to developing lymphoid 
tumors and carcinomas. Importantly, A-T patients have an extreme overreaction to 
radiotherapy treatment. This is reflected in the hypersensitivity of A-T cells to ionizing 
radiation, likely resulting from a deficiency in repair of DSB in heterochromatin. In 
addition they are deficient in many of the ionizing radiation damage-induced cell-cycle 
checkpoints. Since ATM regulates many signal transduction pathways that are elicited by 
ionizing radiation damage, phosphorylating substrates including p53, CHK2 and MDM2, 
deficiencies in these pathways likely contribute the pleiotropic nature of the disorder 
(Lavin, 2008). See also Cell Cycle Checkpoint Genes and Cancer 
A heterotrimeric complex of proteins, RAD50/MRE11/NBS1 (the „MRN‟ complex) has an 
important role in recognition of DSB‟s and recruits ATM to the sites of damage (Stracker 
et al., 2004). An A-T-like disorder (A-T-LD) was found to be caused by hypomorphic  
mutations in the gene encoding the MRE11 protein. These patients present with an 
attenuated/less severe, later onset form of A-T (Stewart et al., 1999). Interestingly no 
cancer predisposition has been reported in A-T-LD to date, unlike in A-T. Defects in the 
gene encoding the NBS1 protein component of the MRN complex result in the Nijmegen 
breakage syndrome (NBS). In contrast to A-T and A-T-LD the principal features are 
microcephaly, mental and growth retardation, but also with immune deficiencies and 
cancer predisposition (Taylor et al., 2004). NBS cells are, like A-T and A-T-LD cells, 
deficient in most of the cell-cycle checkpoints and also have similar defects in repair of 
DSB‟s following ionizing radiation (Digweed and Sperling, 2004). Interestingly, in 
response to ionizing radiation, both MRE11 and NBS1 proteins are phosphorylated by 
ATM. 
  
5.2 Defective ATR-function and human syndromes 
Despite the functional overlap between ATM and ATR, mutation in ATR is associated with 
a clinically distinct disorder from that of A-T. A hypomorphic mutation that impacts on 
correct splicing of ATR has been found to cause Seckel syndrome, a severe form of 
microcephalic proportionate dwarfism (O'Driscoll et al., 2003). Cells from these patients 
exhibit increased DNA replication fork stalling and defective checkpoint activation in 
response to UV and not ionising radiation. Interestingly, other disorders that superficially 
exhibit clinical overlap with Seckel syndrome, such as NBS and MCPH1-associated 
Primary Microcephaly, phenocopy ATR-defective Seckel syndrome cells. In fact, 
mutations in the gene encoding Pericentrin (PCNT), a core centrosomal protein, which 
are also associated with Seckel syndrome and a related condition, Microcephalic 
osteodysplastic primordial dwarfism type II, are also associated with defective ATR-
dependent checkpoint activation. A recent „humanised‟ mouse model of ATR-Seckel 
syndrome (i.e. modelling the human ATR mutation) suggests ATR-deficiency results in 
embryonic replicative stress, reinforcing the concept of „intrauterine‟ programming, the 
notion that events occurring in utero can result in overt, irreversible clinical outcomes 
post-natally (O'Driscoll, 2009).    
  
6. Disorders of Deoxyribonucleic acid Interstrand Cross-link Repair  
DNA interstrand cross-links are produced in DNA by bifunctional chemicals such as 
mitomycin C, nitrogen mustard and psoralens in combination with UV-A treatment. 
Patients with Fanconi anemia (FA) exhibit progressive aplastic anaemia, skeletal 
abnormalities (hypoplastic radii) and lymphoid malignancy (Moldovan and D'Andrea, 
2009). As with A-T, chromosome abnormalities are found in lymphoid cells, but the type 
of aberration differs from those found in A-T. Curiously, cells from FA patients are 
specifically hypersensitive to killing by cross-linking agents, implying a defect in the 
repair of this kind of lesion. The exact mechanism of DNA interstrand cross-link repair 
has not been determined, although elements of HR, NER and other DNA repair pathways 
are co-opted or combine to facilitate repair in this context (Moldovan and D'Andrea, 
2009). FA cells are also slightly sensitive to ionizing radiation. FA can result from a 
mutation in any of 13 FANC genes. Eight of the FANC proteins form a nuclear complex 
which binds to DNA via the FANCM protein and forms a ubiquitin ligase via the FANCL E3 
ligase. In response to DNA damage, this ligase is activated and ubiquitylates the 
FANCD2/FANCI heterodimer.  This modified heterodimer colocalizes with HR proteins in 
nuclear foci. The functional link between FA-pathway and HR is further illustrated by the 
fact that the FANCD1-complementation group of FA patients are mutated in the BRCA2 
gene and the FANCN gene encodes the BRCA2 partner PALB2(Moldovan and D'Andrea, 
2009).  Thus there are important links between FA and both genes involved in familial 
breast cancer. The way in which the FANC proteins facilitate repair of crosslinks and the 
relationship between defective FANC proteins and the specific clinical spectrum of this 
disorder is currently unclear. See also DNA Interstrand Crosslink Repair 
10.1002/9780470015902.a0000575.pub2 
  
7. Disorders of Mismatch Repair  
Although DNA replication is very accurate, mistakes are occasionally made, resulting in 
either mismatched bases or small insertions or deletions. These errors are repaired by 
the mismatch repair system, in which the mismatch is first recognized by one of two 
heterodimers, MSH2/MSH6 (for mismatched bases or small insertion/deletions) or 
MSH2/MSH3 (larger insertion/deletions). A second heterodimeric protein MLH1/PMS2 is 
then recruited, and a complex mechanism for removing and repairing the mismatched 
base(s) ensues (Jiricny, 2006). Hereditary nonpolyposis colon carcinoma (HNPCC) is 
caused in nearly all cases by defective mismatch repair. In this autosomal dominant 
condition, patients inherit a heterozygous mutation in a mismatch repair gene, and in 
tumor cells the second allele is mutated or lost. The majority of cases result from 
mutations in the genes encoding the MSH2 or MLH1 proteins, with rare cases mutated in 
the genes coding for PMS2 and MSH6. Since mismatch repair is a vital mutation 
avoidance mechanism in all cells, the reason for the specificity of the tumor type remains 
a matter of speculation. See also Colorectal Cancer: Genetics, and Mismatch Repair 
Genes 
8. Disorders of base excision and single-strand break repair 
Lesions that produce minor distortions in DNA, like some types of oxidative and 
methylated lesions, are removed by base-excision repair (BER) (Figure 5). The first step 
in BER is the removal of the damaged base by a glycosylase, which cleaves the bond 
between the damaged base and the deoxyribose sugar. The resulting “AP site” where the 
base is lost is cleaved by an endonuclease to generate a single-strand break, which is 
further processed and repaired. 8-oxoguanine is the most common base alteration 
generated by oxidative damage. It can adopt a different configuration such that it can 
base pair with adenine. Subsequently this erroneous pairing is recognised and the 
misincorporated adenine is removed by a glycosylase designated Myh. Biallelic mutations 
in the MYH gene result in a predisposition to multiple colorectal adenomas and 
carcinoma. 
Uracil can be generated in DNA by hydrolytic deamination of cytosine or by 
misincorporation of dUTP. In cells of the immune system, uracil is an intermediate in the 
generation of immune diversity by hypermutation and class switching. It is produced by 
the action of AID (activation-induced cytidine deaminase) and is then cleaved from the 
DNA by uracil-DNA glycosylase (UNG). Some patients with hyper-IgM syndrome are 
mutated in the UNG gene (Figure 5) and this results in defective class switch 
recombination and hypermutation. 
[figure 5 here] 
Spinocerebellar ataxia with axonal neuropathy (SCAN1) results from mutations in the TDP1 
gene. Topoisomerases are enzymes that are able to alter the degree of topological twisting 
of DNA molecules. An intermediate in this process is the formation of a complex in which a 
tyrosine residue in the topoisomerase is covalently bound to the end of a cleaved DNA 
molecule. Anti-cancer drugs like camptothecin block the topoisomerase reaction at the stage 
of this so-called cleavable complex. Tdp1 catalyzes the hydrolysis of the tyrosyl-3' 
phosphate linkage found in these topoisomerase I–DNA covalent complexes (Figure 5). 
Inside cells this is manifested as a reduced ability to repair single-strand breaks, and 
possibly double strand breaks. Persisting DNA breaks in the cerebellum may lead to the 
neurodegeneration associated with this disorder. (Caldecott, 2008) 
Another neurological disorder, ataxia-oculomotor apraxia type 1 (AOA-1), is characterized 
by cerebellar atrophy and sensorimotor neuropathy. Clinical manifestations include 
disturbances in motor coordination from an early age, oculomotor apraxia, loss of 
reflexes, and progressive disability. The APTX gene defective in this disorder encodes 
aprataxin, whose function again appears to involve the removal of abortive 
intermediates in the repair of DNA breaks. In this case the intermediate is formed during 
DNA ligation. An intermediate of DNA ligase reactions involves the addition of an 
adenylate group to the 5‟ end of the break, which is usually removed during the final 
step of DNA ligation by nucleophilic attack by the 3‟-OH group. If the break does not 
have a clean 3‟-OH, however, the adenyl group can persist on the 5‟-end of the break 
and require aprataxin for its removal (Figure 5) (Rass et al., 2007). In AOA1 it is 
possible that defective aprataxin results in the gradual build up of breaks in the 
cerebellar DNA. 
 
  
9. Disorders of RecQ Helicases (Chu and Hickson, 2009) 
The RecQ helicase of Escherichia coli is a multifunctional protein involved in the initiation 
of homologous recombination and suppression of illegitimate recombination. There are 
five human homologues of RECQ, and mutations in three of them result in genetic 
disorders. Bloom syndrome (BLM) is characterized by reduced stature, a high incidence 
of many types of cancers, especially of the lymphoreticular system, reduced fertility and 
chromosome abnormalities. A hallmark is a very high frequency of sister chromatid 
exchanges in Bloom cells. A major function of BLM protein is the dissolution of 
recombination intermediates (Wu and Hickson, 2003). See also DNA Helicase-deficiency 
Disorders 
Werner syndrome (WRN) patients have many features of premature aging, such as loss 
of skin elasticity, graying hair, cataracts, loss of adipose tissue, atherosclerosis and 
increased risk of soft tissue sarcomas. They do not, however, develop dementia. 
Chromosome instability is manifested differently from that in BLM. There is a high 
frequency of illegitimate recombination. Both the BLM and WRN proteins are RecQ-like 
helicases with 3‟ to 5‟ polarity. In addition, WRN, uniquely in the RecQ family, has 3‟–5‟ 
exonuclease activity. The substrate specificities of the two helicases are very similar, and 
the exact roles of these helicases are not yet understood. The properties of the cells and 
the proteins are consistent with a role in resolving topological or structural abnormalities 
that arise during DNA replication. 
Individuals with Rothmund–Thompson syndrome have various abnormalities of the skin 
and skeleton, and some increase in cancer incidence, especially of skin cancers and 
osteosarcomas. Patients are mutated in the RecQ protein-like 4 (RECQL4) gene, but little 
is known about its function. 
10. Cohesinopathies 
After cells have replicated their DNA, the two sister chromatids of each chromosome are 
held together by a protein complex called cohesin, which is thought to form a ring-like 
structure that embraces the two sister chromatids. Cohesin contains four components, 
Smc1, Smc3, Scc1 and Scc3. This complex is loaded onto chromatin by Scc2/Nipbl-Scc4, 
and establishment of cohesion involves the acetylation of Smc3 by Esco2 
acetyltransferase. When double-strand breaks are introduced into a chromatid, cohesin 
accumulates at the break site and assists in repairing the break by recombination with 
the intact sister. Cornelia de Lange Syndrome and Roberts syndrome, conditions 
characterised by multiple congenital abnormalities result from defects in the cohesion 
pathway. Interestingly Cornelia de Lange syndrome cells have been shown to be 
defective in HR. More than 60% of the former are mutated in Scc2, Smc1 or Smc3, 
whereas the latter is caused by mutations in Esco2 (Bose and Gerton, 2010).  
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Cockayne syndrome Type A MIM 216400 
 Cockayne syndrome Type B; MIM 133540.  
   
 
   
Xeroderma pigmentosum Group A MIM 278700 
 
   
Xeroderma pigmentosum Group B MIM 610651 
 
   
Xeroderma pigmentosum Group C MIM 278720 
 
   
Xeroderma pigmentosum Group D MIM 278730 
 
   
Xeroderma pigmentosum Group E MIM 278740 
 
   
Xeroderma pigmentosum Group F MIM 278760 
 
   
Xeroderma pigmentosum Group G MIM 278780 
 
   
Xeroderma pigmentosum variant MIM 278750  
 Ataxia-telangiectasia MIM 208900 
 Nijmegen Breakage Syndrome MIM 251260 
 Ataxia-telangiectasia like disorder MIM 604391 
 Seckel syndrome MIM 210600 
 Fanconi Anemia MIM 227650 
 Spinocerebellar ataxia with axonal neuropathy;SCAN1 MIM 607250 
 Ataxia, oculomotor apraxia type 1 MIM 208920 
 Bloom Syndrome MIM 210900 
 Werner Syndrome MIM 277700 
 Rothmund-Thomson Syndrome MIM 268400 
 Cornelia de Lange syndrome MIM 122470 
 Roberts syndrome MIM 268300 
See also 
DNA Damage Response, DNA Repair, DNA Repair: Evolution, Mismatch Repair Genes, 
and Transcription-coupled DNA Repair  
 
 
 
Figure 1. Different steps in nucleotide excision repair (NER), showing the involvement of 
the different xeroderma pigmentosum (XP) and Cockayne syndrome (CS) proteins. 
(Modified from Volker et al. 2001) 
 
 
 
Figure 2. Patients with (a) xeroderma pigmentosum, (b) trichothiodystrophy and (c) 
Cockayne syndrome. 
 
 
 
Figure 3. The steps of double-strand break repair by nonhomologous end joining.  
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Figure 4 DNA damage signalling 
The red arrows indicate ATM-dependent phosphorylation events. The mediators enhance 
ATM-dependent signalling. Phosphorylated H2AX is referred to as H2AX. 
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Figure 5 The steps of Base excision repair.   represents a damaged or 
inappropriate base, some examples of which are shown on the following line. These 
bases are cleaved of the backbone by the indicated glycosylases. Disorders resulting 
from enzymatic defects are indicated in parentheses below the enzyme. 
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